Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-940,783
| Closed | -$24M | – | 617 |
|
|
2025
Q3 | $24M | Sell |
940,783
-4,709,790
| -83% | -$116M | 0.31% | 59 |
|
|
2025
Q2 | $137M | Buy |
5,650,573
+2,349,058
| +71% | +$54.8M | 1.54% | 11 |
|
|
2025
Q1 | $83.7M | Buy |
3,301,515
+3,035,820
| +1,143% | +$79.4M | 1.17% | 17 |
|
|
2024
Q4 | $7.05M | Buy |
265,695
+81,496
| +44% | +$2.21M | 0.12% | 115 |
|
|
2024
Q3 | $5.33M | Sell |
184,199
-9,720
| -5% | -$284K | 0.1% | 100 |
|
|
2024
Q2 | $5.43M | Buy |
193,919
+13,276
| +7% | +$366K | 0.1% | 109 |
|
|
2024
Q1 | $5.01M | Buy |
180,643
+27,249
| +18% | +$756K | 0.09% | 141 |
|
|
2023
Q4 | $4.42M | Sell |
153,394
-226,775
| -60% | -$6.86M | 0.07% | 129 |
|
|
2023
Q3 | $12.6M | Sell |
380,169
-160,777
| -30% | -$5.69M | 0.22% | 86 |
|
|
2023
Q2 | $19.8M | Buy |
540,946
+338,042
| +167% | +$13.2M | 0.36% | 65 |
|
|
2023
Q1 | $8.28M | Sell |
202,904
-415,066
| -67% | -$17.9M | 0.17% | 97 |
|
|
2022
Q4 | $31.7M | Buy |
617,970
+467,257
| +310% | +$22.4M | 0.82% | 33 |
|
|
2022
Q3 | $6.59M | Buy |
150,713
+77,732
| +107% | +$3.78M | 0.19% | 95 |
|
|
2022
Q2 | $3.83M | Sell |
72,981
-652,359
| -90% | -$33.2M | 0.12% | 129 |
|
|
2022
Q1 | $37.6M | Buy |
725,340
+371,217
| +105% | +$19.3M | 0.98% | 25 |
|
|
2021
Q4 | $20.9M | Buy |
354,123
+40,507
| +13% | +$2.01M | 0.55% | 48 |
|
|
2021
Q3 | $13.5M | Buy |
313,616
+17,703
| +6% | +$784K | 0.38% | 53 |
|
|
2021
Q2 | $12.7M | Buy |
295,913
+187,990
| +174% | +$7.31M | 0.34% | 56 |
|
|
2021
Q1 | $3.91M | Buy |
107,923
+104,956
| +3,537% | +$3.73M | 0.12% | 121 |
|
|
2020
Q4 | $109K | Sell |
2,967
-642,470
| -100% | -$23.6M | ﹤0.01% | 350 |
|
|
2020
Q3 | $22.5M | Buy |
645,437
+420,431
| +187% | +$14.7M | 0.94% | 22 |
|
|
2020
Q2 | $6.98M | Buy |
225,006
+119,843
| +114% | +$4.07M | 0.45% | 46 |
|
|
2020
Q1 | $3.26M | Sell |
105,163
-698,869
| -87% | -$23.8M | 0.22% | 92 |
|
|
2019
Q4 | $29.9M | Buy |
804,032
+227,196
| +39% | +$8.09M | 2.28% | 10 |
|
|
2019
Q3 | $19.7M | Sell |
576,836
-51,237
| -8% | -$1.86M | 1.37% | 17 |
|
|
2019
Q2 | $25.8M | Buy |
628,073
+142,457
| +29% | +$5.66M | 2.01% | 12 |
|
|
2019
Q1 | $19.6M | Buy |
485,616
+477,521
| +5,899% | +$19.1M | 1.61% | 17 |
|
|
2018
Q4 | $335K | Buy |
+8,095
| New | +$336K | 0.05% | 164 |
|
Other funds holding PFE
Ossiam's PFE Position: Q4 2025 in Review
Ossiam sold out of Pfizer (PFE) in Q4 2025, closing a stake of 940,783 shares — an estimated $24M sold.
Ossiam first reported a position in PFE in Q4 2018 and held it in 28 quarters. The position peaked at $137M in Q2 2025. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Ossiam reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Ossiam sold 940,783 Pfizer shares in Q4 2025, an estimated $24M.
- Ossiam first reported a position in Pfizer in Q4 2018 and held it in 28 quarters.
- Ossiam's Pfizer position peaked at $137M in Q2 2025.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Ossiam's 13F filing for Q4 2025, filed 13 Feb 2026.